Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMPEDIMED LIMITED Capital/Financing Update 2014

Nov 19, 2014

65135_rns_2014-11-19_bdbc6c48-ef80-4f98-909d-c8c7864aeb1f.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [99 x 29] intentionally omitted <==

==> picture [99 x 29] intentionally omitted <==

==> picture [99 x 29] intentionally omitted <==

20 November 2014

FOR IMMEDIATE RELEASE

The Manager Company Announcements Office ASX Limited Level 4, Exchange Centre 20 Bridge Street SYDNEY NSW 2000

ImpediMed confirms number of shares to be issued under entitlement offer

As foreshadowed on 13 November 2014, ImpediMed Limited (ABN 65 089 705 144) (ASX: IPD) ( ImpediMed ) now confirms that it will issue a total of approximately 54.2 million new fully paid ordinary shares under its non-renounceable pro rata entitlement offer, raising a total of approximately A$32.5 mllion before costs and expenses.

The entitlement offer opens for acceptance by Eligible Shareholders (as defined in the Offer Booklet for the offer) at 9.00am (AEDT) on 24 November 2014. On that date, ImpediMed will send the Offer Booklet to Eligible Shareholders.

-ENDS-

For further details contact:

Steve Denaro

Company Secretary ImpediMed Limited T: +61 7 3860 3700

ImpediMed Limited ABN 65 089 705 144

Unit 1, 50 Parker Court, Pinkenba, QLD 4008 Australia • Tel +61 (7) 3860-3700 Fax +61 (7) 3260-1225 www.impedimed.com